<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04931316</url>
  </required_header>
  <id_info>
    <org_study_id>R.20.12.1121</org_study_id>
    <nct_id>NCT04931316</nct_id>
  </id_info>
  <brief_title>Incidence and Management of Ocular Hypertension Following Deep Anterior Lamellar Keratoplasty</brief_title>
  <acronym>Dalk</acronym>
  <official_title>Incidence and Management of Ocular Hypertension Following Deep Anterior Lamellar Keratoplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a retrospective case series study that included patients who performed deep anterior&#xD;
      lamellar keratoplasty and presented with elevated intraocular pressure during follow up.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a retrospective case series study that included patients who performed deep anterior&#xD;
      lamellar keratoplasty and presented with elevated intraocular pressure during follow up.&#xD;
      Patients' demographic characteristics, medical, and ocular history will be recorded.&#xD;
&#xD;
      Inclusion criteria will include patients who were diagnosed with elevated intraocular&#xD;
      pressure (IOP) after DALK surgery performed from 2018 to 2020 with follow up duration more&#xD;
      than 6 months. Patients with less than 6 months of follow-up will be excluded from the study.&#xD;
&#xD;
      Patients' demographic characteristics, medical and ocular history will be recorded. Baseline&#xD;
      complete ophthalmic examination was performed. It included best corrected visual acuity&#xD;
      (BCVA) using Landolt C chart that was converted to log minimum angle of resolution (log MAR)&#xD;
      for statistical analysis, slit lamp anterior segment examination (with attention to cornea,&#xD;
      bulbar conjunctiva and AC), intraocular pressure measurement using rebound system (I care&#xD;
      tonometer, Topcon, Canada), angle assessment and fundus examination using Goldman 3 mirror&#xD;
      contact lens.&#xD;
&#xD;
      High IOP was defined as intraocular pressure more than 25 mmHg. Data will be collected with&#xD;
      attention to appropriate management done either medical treatment or surgical intervention.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 15, 2021</start_date>
  <completion_date type="Anticipated">October 20, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 20, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Intraocular pressure values</measure>
    <time_frame>this is a retrospective study . collection of data from patients records over 2 months</time_frame>
    <description>assessment of intraocular pressure after lamellar keratoplasty</description>
  </primary_outcome>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Unrecognized Condition</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>antiglaucoma</intervention_name>
    <description>use antiglaucoma in ocular hypertension</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with DALK&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients who were diagnosed with elevated IOP after DALK surgery performed from 2018&#xD;
             to 2020&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with penetrating keratoplasty&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>AHMED El WEHEDY, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mansoura University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hatem El Awady, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Mansoura University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>AYA HASHISH, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Mansoura University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>AMGAD EL NOKRASHY, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Mansoura University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amgad El Nokrashy, MD</last_name>
    <phone>00201022187736</phone>
    <email>amgad.ali@mans.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Aya Hashish, MD</last_name>
    <phone>00201004701791</phone>
    <email>aya.hashish@mans.edu.eg</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mansoura university</name>
      <address>
        <city>Mansoura</city>
        <state>Dakahlyia</state>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amgad El Nokrashy, MD</last_name>
      <phone>00201022187736</phone>
      <email>amgad.ali@mans.edu.eg</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 12, 2021</study_first_submitted>
  <study_first_submitted_qc>June 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 18, 2021</study_first_posted>
  <last_update_submitted>June 18, 2021</last_update_submitted>
  <last_update_submitted_qc>June 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Amgad Mahmoud El Nokrashy</investigator_full_name>
    <investigator_title>Lecturer of Ophthalmology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ocular Hypertension</mesh_term>
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

